title: The Ebola epidemic crystallizes the potential of passive antibody therapy for infectious diseases.
authors.affiliation: Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America.
authors.forename: Arturo
authors.initials: A
authors.lastname: Casadevall
authors.affiliation: Department of Microbiology and Immunology, Albert Einstein College of Medicine, New York, New York, United States of America; Department of Medicine (Infectious Diseases), Albert Einstein College of Medicine, New York, New York, United States of America.
authors.forename: Liise-Anne
authors.initials: LA
authors.lastname: Pirofski
mesh_terms: D058872:Epidemics / Q000517:prevention & control*; D019142:Hemorrhagic Fever, Ebola / Q000453:epidemiology / Q000517:prevention & control*; D006801:Humans; D007116:Immunization, Passive / Q000379:methods*